EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 270 filers reported holding EXELIXIS INC in Q3 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $204,000 | -97.5% | 6,700 | -97.9% | 0.00% | -96.7% |
| Q2 2017 | $8,039,000 | +77.9% | 326,384 | +56.5% | 0.12% | +81.8% |
| Q1 2017 | $4,519,000 | +1890.7% | 208,524 | +1269.8% | 0.07% | +1550.0% |
| Q4 2016 | $227,000 | -72.6% | 15,223 | -76.5% | 0.00% | -69.2% |
| Q3 2016 | $827,000 | -85.3% | 64,700 | -95.7% | 0.01% | -81.7% |
| Q2 2015 | $5,613,000 | +737.8% | 1,492,700 | +472.8% | 0.07% | +688.9% |
| Q1 2015 | $670,000 | +472.6% | 260,600 | +653.7% | 0.01% | +800.0% |
| Q2 2014 | $117,000 | – | 34,577 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |